Prothena Corp (PRTA) PT Raised to $64 at Oppenheimer, Following Clinical Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| PROTHENA CORP (NASDAQ: PRTA) | Delayed: 8.43 +0.22 (2.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.21 | 52 Week High | $76.42 | |||
| Open | $8.48 | 52 Week Low | $28.20 | |||
| Day High | $8.56 | P/E | N/A | |||
| Day Low | $8.30 | EPS | $-2.84 | |||
| Volume | 123,703 | |||||
